379 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page
of 8 | next »
HTR3D 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic Predicted membrane proteins Transporters Not detected
HVCN1 Hydrogen voltage gated channel 1 Predicted intracellular proteins Predicted membrane proteins Transporters Mixed
IPO11 Importin 11 Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transporters Nucleus Nucleoli fibrillar center Expressed in all
IPO13 Importin 13 Predicted intracellular proteins Transporters Expressed in all
IPO4 Importin 4 Predicted intracellular proteins Transporters Cytosol Tissue enhanced
IPO5 Importin 5 Plasma proteins Predicted intracellular proteins Transporters Nucleoplasm Cytosol Expressed in all
IPO7 Importin 7 Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters Nucleoplasm Cytosol Expressed in all
IPO8 Importin 8 Predicted intracellular proteins Transporters Nucleus Expressed in all
IPO9 Importin 9 Predicted intracellular proteins Predicted secreted proteins Transporters Vesicles Cytosol Expressed in all
ITPR1 Inositol 1,4,5-trisphosphate receptor, type 1 Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Vesicles Tissue enhanced
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNF1 Potassium channel, voltage gated modifier subfamily F, member 1 Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Tissue enriched
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enriched
KCNH2 Potassium channel, voltage gated eag related subfamily H, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNH3 Potassium channel, voltage gated eag related subfamily H, member 3 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleus Mitochondria Group enriched
KCNJ1 Potassium channel, inwardly rectifying subfamily J, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNJ13 Potassium channel, inwardly rectifying subfamily J, member 13 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
KCNJ16 Potassium channel, inwardly rectifying subfamily J, member 16 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Group enriched
KCNJ2 Potassium channel, inwardly rectifying subfamily J, member 2 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNJ3 Potassium channel, inwardly rectifying subfamily J, member 3 Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNJ5 Potassium channel, inwardly rectifying subfamily J, member 5 Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNJ6 Potassium channel, inwardly rectifying subfamily J, member 6 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNJ8 Potassium channel, inwardly rectifying subfamily J, member 8 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNK15 Potassium channel, two pore domain subfamily K, member 15 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK16 Potassium channel, two pore domain subfamily K, member 16 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK3 Potassium channel, two pore domain subfamily K, member 3 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleus Tissue enhanced
KCNK6 Potassium channel, two pore domain subfamily K, member 6 Predicted membrane proteins Transporters Voltage-gated ion channels Plasma membrane Actin filaments Cytosol Mixed
KCNK9 Potassium channel, two pore domain subfamily K, member 9 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
KCNN2 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Cytosol Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Endoplasmic reticulum Tissue enriched
KCNQ3 Potassium channel, voltage gated KQT-like subfamily Q, member 3 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNS1 Potassium voltage-gated channel, modifier subfamily S, member 1 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Plasma membrane Cytosol Tissue enhanced
KCNT1 Potassium channel, sodium activated subfamily T, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
KCNT2 Potassium channel, sodium activated subfamily T, member 2 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enhanced
KPNA1 Karyopherin alpha 1 (importin alpha 5) Predicted intracellular proteins Transporters Nucleus Cytosol Expressed in all
KPNA2 Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) Plasma proteins Predicted intracellular proteins Transporters Nucleoplasm Cytosol Expressed in all
KPNA3 Karyopherin alpha 3 (importin alpha 4) Predicted intracellular proteins Transporters Nucleoplasm Cytosol Expressed in all
« prev | Page
of 8 | next »